Hiroyuki Matsushima Selected Research

Intravitreal Injections

1/2011

Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Matsushima Research Topics

Disease

7	Capsule Opacification 01/2019 - 01/2004
6	Cataract (Cataracts) 09/2009 - 03/2004
1	Inflammation (Inflammations) 03/2019
1	Aphakia 12/2014
1	Endophthalmitis (Ophthalmia) 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2006

Drug/Important Bio-Agent (IBA)

7	Capsules (Microcapsules)IBA 01/2019 - 03/2004
2	CalciumIBA 05/2006 - 03/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Bevacizumab (Avastin)FDA Link 01/2011
1	Biological ProductsIBA 03/2008
1	Polymethyl Methacrylate (Sol)IBA 06/2007
1	ArgonIBA 06/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2006
1	Viscoelastic SubstancesIBA 01/2006
1	AntibodiesIBA 01/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2006
1	Bovine Serum AlbuminIBA 03/2004
1	HydrogelsIBA 01/2004
1	Cytoskeletal ProteinsIBA 01/2004

Therapy/Procedure

6	Intraocular Lenses (Intraocular Lens) 01/2019 - 01/2004
1	Sutures (Suture) 03/2019
1	Intraocular Lens Implantation 12/2014
1	Intravitreal Injections 01/2011